Rocket Lab Is Up 15x in Two Years. Is It Too Late?

Rocket Lab shares climbed from $4.10 in late March 2024 to over $64 today (~15x in two years) and are ~32% off their highs (implying >50% upside to recover). Analysts expect profitability by 2027 and project 2030 EBITDA of ~$640M (up from $548M four months ago), implying roughly 36x 2030 EBITDA; the company also announced a $190M contract described as its "biggest contract ever." The article flags a 93% probability of a SpaceX IPO this year (claiming a potential $1.75T raise) as a major sector catalyst that could re-rate space peers, alongside structural tailwinds such as cheaper reusable launches, rising orbital launches (102 in 2019 vs 324 in 2025) and defense spending including a $23B allocation for the "Golden Dome" project.

Analysis

RKLB sits at the intersection of sentiment-driven rerating and real capacity constraints; the market is now pricing a multi-year margin expansion that requires both steady launch cadence and higher-margin services (rideshare/payload integration, in-orbit ops). That implies the hardest part of the bull case is industrial execution — factory throughput, engine life-cycle costs, and recurring service contracts — not the top-line demand. Expect incremental EBITDA upside to come in lumpy quarters tied to contract awards and successful reuse cycles rather than a smooth linear beat.

A SpaceX IPO (or any headline liquidity event) is a binary sentiment magnifier, not the sole fundamental underpin — it will reallocate marginal capital but won’t fix customer concentration or schedule risk. Near-term reversals are most likely from a single high-profile failure, a string of launches delayed by supply-chain bottlenecks, or defense spending pivoting away from planned procurements; these risks unfold on 0-12 month horizons and can erase >30% of market value quickly. Over 12-36 months, the higher-probability path is consolidation of pricing power for reliable launch providers, which benefits firms that convert backlog into predictable free cash flow.

Second-order winners are niche suppliers and integration specialists who capture growing per-launch revenue; broad semiconductor vendors (NVDA/AMD/INTC) are a thematic play only if on-orbit compute scales materially, a 3+ year outcome. The current market is underweight the execution risk embedded in forward multiples, so tactical structures that buy the re-rate while capping downside are preferable to naked long exposure funded by momentum alone.

Key Decisions for Investors

• Long RKLB equity (size 1.0–1.5% NAV), time horizon 12–24 months. Target +75–100% if cadence and margin beats persist; tactical stop at -30% from entry. Hedge by buying a 9–12 month RKLB put at ~25% OTM sized to 50% of the equity position to cap drawdown while keeping upside participation.
• Pair trade: Long RKLB / Short SPCE (equal notional, 0.5–1.0% NAV per leg), horizon 6–12 months. Rationale: isolates pure launch-services rerate vs consumer/experience-facing space exposure; target spread improvement of 30–50%. Cut both legs on macro-driven liquidity shock (>15% decline in Nasdaq 100).
• Defined-risk options: Buy a 12–18 month RKLB call spread (buy ATM, sell ~2x ATM) sized 0.5% NAV. Max loss = premium; target 2.5–3x return if market re-rates on sustained contract wins and margin expansion.
• Volatility hedge / income: If conviction is medium-term constructive but expect near-term chop, sell short-dated RKLB covered calls (4–8 week) on up days vs a dedicated long base to trim carry. Limit covered-call exposure to 25% of long position to avoid capping meaningful upside after positive catalysts.